Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade.
Tesfay MZ, Zhang Y, Ferdous KU, Taylor MA, Cios A, Shelton RS, Simoes CC, Watters CR, Barro O, Elliott NM, Mustafa B, Chamcheu JC, Graham AL, Washam CL, Alkam D, Gies A, Byrum SD, Giorgakis E, Post SR, Kelly T, Ying J, Moaven O, Chabu CY, Fernandez-Zapico ME, Duda DG, Roberts LR, Govindarajan R, Borad MJ, Cannon MJ, Basnakian AG, Nagalo BM. Tesfay MZ, et al. Among authors: duda dg. Mol Ther Oncol. 2024 Nov 26;32(4):200913. doi: 10.1016/j.omton.2024.200913. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39758249 Free PMC article.
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.
Chamseddine S, Yavuz BG, Mohamed YI, Lee SS, Yao JC, Hu ZI, LaPelusa M, Xiao L, Sun R, Morris JS, Hatia RI, Hassan M, Duda DG, Diab M, Mohamed A, Nassar A, Amin HM, Kaseb AO. Chamseddine S, et al. Among authors: duda dg. J Immunother Precis Oncol. 2024 Nov 1;7(4):255-262. doi: 10.36401/JIPO-24-6. eCollection 2024 Nov. J Immunother Precis Oncol. 2024. PMID: 39524465 Free PMC article.
Involuted TLS as a harbinger of HCC regression.
Liu X, Duda DG. Liu X, et al. Among authors: duda dg. Nat Immunol. 2024 Nov;25(11):1986-1987. doi: 10.1038/s41590-024-01990-y. Nat Immunol. 2024. PMID: 39455892 No abstract available.
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.
LaPelusa M, Chamseddine S, Tran Cao HS, Xiao L, Hasanov E, Bhosale P, Amin HM, Mohamed YI, Gok Yavuz B, Sakr Y, Xu L, Hu I, Lee SS, Sakamuri D, Jindal S, Nguyen V, Curran MA, Sun R, Rashid A, Duda DG, Sharma P, Qayyum A, Kaseb AO. LaPelusa M, et al. Among authors: duda dg. Oncology. 2024 Oct 18:1-8. doi: 10.1159/000541250. Online ahead of print. Oncology. 2024. PMID: 39427654 Free article.
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Park RJ, Parikh M, Pappas L, Sade-Feldman M, Kulkarni AS, Bi L, LaSalle TJ, Galway A, Kuhlman C, Blaszkowsky LS, Meyerhardt JA, Enzinger PC, Biller L, Allen JN, Kagey MH, Baum J, Sirard C, Duda DG, Zhu AX, Abrams TA, Hacohen N, Ting DT, Mehta A, Goyal L. Park RJ, et al. Among authors: duda dg. medRxiv [Preprint]. 2024 Oct 8:2024.10.08.24315092. doi: 10.1101/2024.10.08.24315092. medRxiv. 2024. PMID: 39417106 Free PMC article. Preprint.
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy.
Wu B, Tapadar S, Ruan Z, Sun CQ, Arnold RS, Johnston A, Olugbami JO, Arunsi U, Gaul DA, Petros JA, Kobayashi T, Duda DG, Oyelere AK. Wu B, et al. Among authors: duda dg. ACS Pharmacol Transl Sci. 2024 Sep 5;7(10):3155-3169. doi: 10.1021/acsptsci.4c00358. eCollection 2024 Oct 11. ACS Pharmacol Transl Sci. 2024. PMID: 39416967
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Ho AY, Shiao S, Kobald SA, Chen J, Duda DG, Ly A, Bossuyt V, Cho HL, Arnold B, Knott S, Gupta GP, McAndrew P, Karlan S, Tighiouart M, Muzikansky A, Basho R, McArthur H. Ho AY, et al. Among authors: duda dg. J Clin Oncol. 2024 Dec 20;42(36):4282-4293. doi: 10.1200/JCO.24.00003. Epub 2024 Sep 19. J Clin Oncol. 2024. PMID: 39298718 Clinical Trial.
253 results